Robert LeBoyer
Stock Analyst at Noble Financial
(0.05)
# 4,883
Out of 5,162 analysts
432
Total ratings
24.7%
Success rate
-17.5%
Average return
Main Sectors:
Stocks Rated by Robert LeBoyer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals | Reiterated: Buy | $10 | $2.03 | +392.61% | 25 | Oct 27, 2026 | |
| NNVC NanoViricides | Reiterated: Buy | $6 | $1.19 | +404.20% | 5 | Oct 15, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $12 | $0.7392 | +1,523.38% | 45 | Sep 28, 2026 | |
| MAIA MAIA Biotechnology | Reiterated: Buy | $14 | $1.30 | +976.92% | 24 | Sep 22, 2026 | |
| GOVX GeoVax Labs | Reiterated: Buy | $240 | $1.99 | +11,960.30% | 27 | Sep 17, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $50 | $3.57 | +1,300.56% | 20 | Aug 13, 2026 | |
| NTRB Nutriband | Reiterated: Buy | $15 | $4.82 | +211.20% | 10 | Aug 12, 2026 | |
| NRSN NeuroSense Therapeutics | Reiterated: Buy | $180 | $1.37 | +13,038.69% | 8 | Aug 11, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $20 | $4.34 | +360.83% | 11 | Aug 10, 2026 | |
| CVKD Cadrenal Therapeutics | Reiterated: Buy | $45 | $1.72 | +2,516.28% | 17 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $20.58 | +118.66% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $10 | $0.9769 | +923.65% | 28 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.839 | +1,330.27% | 5 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.20 | +150.00% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $37 | $2.82 | +1,212.06% | 30 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0811 | n/a | 5 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7841 | n/a | 36 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2425 | n/a | 24 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.71 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $0.8385 | n/a | 11 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.73 | $0.03 | n/a | 2 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $20 | $0.7194 | n/a | 10 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $27 | $0.0001 | n/a | 7 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $3.89 | n/a | 8 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.7068 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $14 | $1.37 | n/a | 7 | Jan 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.44 | n/a | 2 | Dec 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.4079 | n/a | 6 | Dec 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 5 | Nov 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.27 | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3532 | n/a | 8 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $1.06 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.29 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.82 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $1 | $16.23 | n/a | 2 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.75 | n/a | 3 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.37 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9801 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.91 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 4 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $54 → $41 | $17.83 | n/a | 2 | Aug 5, 2016 |
Eledon Pharmaceuticals
Oct 27, 2026
Reiterated: Buy
Price Target: $10
Current: $2.03
Upside: +392.61%
NanoViricides
Oct 15, 2026
Reiterated: Buy
Price Target: $6
Current: $1.19
Upside: +404.20%
Ocugen
Sep 28, 2026
Reiterated: Buy
Price Target: $12
Current: $0.7392
Upside: +1,523.38%
MAIA Biotechnology
Sep 22, 2026
Reiterated: Buy
Price Target: $14
Current: $1.30
Upside: +976.92%
GeoVax Labs
Sep 17, 2026
Reiterated: Buy
Price Target: $240
Current: $1.99
Upside: +11,960.30%
Unicycive Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $3.57
Upside: +1,300.56%
Nutriband
Aug 12, 2026
Reiterated: Buy
Price Target: $15
Current: $4.82
Upside: +211.20%
NeuroSense Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $180
Current: $1.37
Upside: +13,038.69%
Gyre Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $4.34
Upside: +360.83%
Cadrenal Therapeutics
Jul 14, 2026
Reiterated: Buy
Price Target: $45
Current: $1.72
Upside: +2,516.28%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $20.58
Upside: +118.66%
May 27, 2026
Reiterated: Buy
Price Target: $6 → $10
Current: $0.9769
Upside: +923.65%
May 22, 2026
Reiterated: Buy
Price Target: $12
Current: $0.839
Upside: +1,330.27%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $3.20
Upside: +150.00%
Mar 16, 2026
Reiterated: Buy
Price Target: $70 → $37
Current: $2.82
Upside: +1,212.06%
Jun 27, 2025
Rated: Hold
Price Target: n/a
Current: $0.0811
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.7841
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.2425
Upside: n/a
Jan 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $5
Current: $1.71
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $8 → $9
Current: $0.8385
Upside: n/a
Jun 1, 2022
Reiterated: Buy
Price Target: $0.73
Current: $0.03
Upside: n/a
May 14, 2021
Reiterated: Buy
Price Target: $20 → $20
Current: $0.7194
Upside: n/a
Feb 9, 2021
Reiterated: Buy
Price Target: $18 → $27
Current: $0.0001
Upside: n/a
Jan 26, 2021
Reiterated: Buy
Price Target: $6 → $15
Current: $3.89
Upside: n/a
Jan 25, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $0.7068
Upside: n/a
Jan 24, 2021
Reiterated: Buy
Price Target: $6 → $14
Current: $1.37
Upside: n/a
Dec 28, 2020
Downgraded: Hold
Price Target: n/a
Current: $4.44
Upside: n/a
Dec 24, 2020
Reiterated: Buy
Price Target: $6
Current: $0.4079
Upside: n/a
Nov 12, 2020
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Oct 5, 2020
Downgraded: Hold
Price Target: n/a
Current: $8.27
Upside: n/a
May 28, 2020
Reiterated: Buy
Price Target: $5
Current: $0.3532
Upside: n/a
Feb 18, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $1.06
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $3.29
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $2.82
Upside: n/a
Apr 10, 2018
Downgraded: Hold
Price Target: $17 → $1
Current: $16.23
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $2.75
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.9801
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.91
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 5, 2016
Downgraded: Hold
Price Target: $54 → $41
Current: $17.83
Upside: n/a